PAIRXBIO Trademark

Biological and pharmaceutical preparations for treatment of inflammation and immunology disorders; biological and pharmaceutical preparations, namely, bi-specifics, multi specifics, T-cell engagers, radioligands and small molecules; Diagnostic preparations for medical purposes; biological and pharmaceutical preparations for treatment of cancer and tumors; human therapeutic vaccine preparations for use in oncology; anti-cancer preparations; therapeutic preparations being solutions, namely, antigens, antibodies, and antibody-drug conjugates; T-cells in the nature of preparations for treatment of cancer and tumors; diagnostic preparations for medical purposes, namely, antigens, antibodies, and cells for therapeutic use; medical preparations, namely, vaccines, antigens, and immunotherapeutic agents for the treatment and prevention of cancers and tumors

Scientific research services for medical purposes; scientific research services for medical purposes in the field of oncology; immunotherapy research; design and development of therapeutic vaccines, immunotherapy and pharmaceutical products; design and development of therapeutic products in oncology; research and development of antigenic and immunotherapeutic agents; research and development in the field of mRNA technology; research and development in the field of therapeutics; providing medical and scientific research information, namely, designing algorithms and models for use in scientific and medical research; providing temporary use of online non-downloadable computer software platforms featuring algorithms for analyzing cells, antigens, tissues, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; providing temporary use of an online non-downloadable computer software platform featuring algorithms for predicting the characteristics of antigens and immunological responses; providing temporary use of an online non-downloadable computer software platform for research and development in the field of therapeutics; platform as a service (paas) featuring computer software platforms for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing RNA sequencing and other multi-omic data; providing temporary use of online non-downloadable computer software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features